None listed
Conditions
Interventions
Radiation : 1. Concurrent Chemoradiotherapy
1.1 Concurrent chemoradiotherapy is recommended to follow a Cisplatin-based regimen and should be performed only during the period of external radiotherapy.
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1 Patients diagnosed histologically with cervical cancer (limited to squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma) 2 Patients who have undergone appropriate clinical staging work-up (including pelvic MRI and PET-CT) 3 Patients with FIGO Stage IVA or lower 4 Adults aged between 20 and 80 5 Patients with an ECOG performance status of 0-1 prior to participation 4.1.6 Patients who have voluntarily signed the informed consent form
Exclusion criteria
Exclusion criteria: 1 Patients with distant metastasis 2 Patients requiring extended field radiotherapy due to metastasis to the common iliac and abdominal lymph nodes 3 Patients who have previously received radiation therapy to the pelvic area 4 Patients with untreated serious acute illnesses other than cervical cancer 5 Patients diagnosed with other cancers (except thyroid and skin cancer) within the past 5 years or who have a recurrent case
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| disease-free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Incidence of grade 3 or higher acute toxicity;Incidence of grade 3 or higher chronic toxicity | — |
Countries
Korea, Republic of
Contacts
Public ContactYeon Joo Kim
Asan Medical Center
Outcome results
None listed